Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49. AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455. Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029. Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036. Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Case and Commentary Jul 2017 How Should Clinicians Counsel a Woman with a Strong Family History of Early-Onset Alzheimer’s Disease about Her Pregnancy? Marianna V. Mapes, Barbara M. O'Brien, MD, and Louise P. King, MD, JD Pregnant women at high risk for heritable diseases need support and nondirective genetic counseling. AMA J Ethics. 2017;19(7):663-674. doi: 10.1001/journalofethics.2017.19.7.ecas4-1707. Medicine and Society Jul 2017 Transcending the Tragedy Discourse of Dementia: An Ethical Imperative for Promoting Selfhood, Meaningful Relationships, and Well-Being Peter Reed, PhD, MPH, Jennifer Carson, PhD, and Zebbedia Gibb, PhD Authentic partnerships with people with dementia motivate full social participation and resist fatalism around experiences of illness. AMA J Ethics. 2017;19(7):693-703. doi: 10.1001/journalofethics.2017.19.7.msoc1-1707. Medicine and Society Jul 2017 Arts Participation: Counterbalancing Forces to the Social Stigma of a Dementia Diagnosis Beth Bienvenu, PhD and Gay Hanna, PhD, MFA Arts participation can counterbalance the social stigma of Alzheimer’s disease by fostering the autonomy and creativity of those with the diagnosis. AMA J Ethics. 2017;19(7):704-712. doi: 10.1001/journalofethics.2017.19.7.msoc2-1707. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49.
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Art of Medicine May 2019 Fading Mind of a Patient With Alzheimer’s Laci Hadorn This artwork represents—via a puzzle—physical and emotional experiences of brain deterioration. AMA J Ethics. 2019;21(5):E455-456. doi: 10.1001/amajethics.2019.455.
Case and Commentary Dec 2019 Using the 4-S Framework to Guide Conversations With Patients About CRISPR Lisa S. Lehmann, MD, PhD, MSc Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences. AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029.
Case and Commentary Dec 2019 How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity? Charis Thompson, PhD Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation. AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Case and Commentary Jul 2017 How Should Clinicians Counsel a Woman with a Strong Family History of Early-Onset Alzheimer’s Disease about Her Pregnancy? Marianna V. Mapes, Barbara M. O'Brien, MD, and Louise P. King, MD, JD Pregnant women at high risk for heritable diseases need support and nondirective genetic counseling. AMA J Ethics. 2017;19(7):663-674. doi: 10.1001/journalofethics.2017.19.7.ecas4-1707.
Medicine and Society Jul 2017 Transcending the Tragedy Discourse of Dementia: An Ethical Imperative for Promoting Selfhood, Meaningful Relationships, and Well-Being Peter Reed, PhD, MPH, Jennifer Carson, PhD, and Zebbedia Gibb, PhD Authentic partnerships with people with dementia motivate full social participation and resist fatalism around experiences of illness. AMA J Ethics. 2017;19(7):693-703. doi: 10.1001/journalofethics.2017.19.7.msoc1-1707.
Medicine and Society Jul 2017 Arts Participation: Counterbalancing Forces to the Social Stigma of a Dementia Diagnosis Beth Bienvenu, PhD and Gay Hanna, PhD, MFA Arts participation can counterbalance the social stigma of Alzheimer’s disease by fostering the autonomy and creativity of those with the diagnosis. AMA J Ethics. 2017;19(7):704-712. doi: 10.1001/journalofethics.2017.19.7.msoc2-1707.